A Farncombe woman has shared her life-changing experience after her lung cancer was diagnosed within hours due to a revolutionary AI tool implemented by the Royal Surrey NHS Foundation Trust.

Dianne Covey, 69, was referred for further investigation after her persistent cough raised red flags, leading to doctors discovering something suspicious on her lungs. The confirmation of lung cancer came after her chest X-ray underwent analysis by Annalise.ai, a cutting-edge AI technology designed to scan for areas of concern in imaging results.

Reflecting on her experience, Ms. Covey expressed appreciation for the role artificial intelligence played in her timely diagnosis: “I never really understood much about artificial intelligence but now I think that it might have saved my life. I am very grateful.” She noted her initial fears about lung cancer when visiting her GP, saying, “I had a bad feeling that it was lung cancer and was really worried.” The rapid identification of her condition, diagnosed at Stage 1, has provided her with renewed hope for her health.

The significance of the AI tool extends beyond speed; hospital representatives indicated that it improves diagnostic accuracy by helping radiographers prioritize which X-rays to assess first. This advancement replaces an older method in which images were reviewed solely in the order they were received. Furthermore, the AI system enhances the detection of even the smallest anomalies on scans, thereby increasing the chances of early intervention.

Currently, this AI tool is being utilized across five trusts within the Surrey, Sussex, and Frimley Imaging Network, which includes the Royal Surrey, Frimley Health NHS Foundation Trust, Ashford and St Peter’s Hospitals NHS Foundation Trust, University Hospitals Sussex NHS Foundation Trust, and East Sussex Healthcare NHS Trust. The ability of AI to deliver rapid and precise diagnostics not only underscores its transformative potential in the healthcare landscape but also represents a promising advancement in the fight against cancer.